メタゲノムシーケンス市場：製品・サービス、ワークフロー、技術、用途別-2025～2030年世界予測

メタゲノムシーケンス市場は、2023年に21億5,000万米ドルと評価され、2024年には23億9,000万米ドルに達すると予測され、CAGR 12.43%で成長し、2030年には48億9,000万米ドルに達すると予測されています。

メタゲノムシーケンスは、環境サンプルの遺伝物質を分析するゲノミクスの画期的なアプローチであり、培養の必要なく微生物群集の包括的な研究を可能にします。このアプローチは、土壌、海洋、ヒト腸内細菌叢などの環境における複雑なマイクロバイオームを理解する上で極めて重要です。その用途は、病原体の発生を検出する臨床診断、土壌の健康状態を評価する農業、汚染物質を浄化するバイオレメディエーション活動など、さまざまなセグメントに及びます。最終用途は、製薬産業、環境機関、学術研究機関、医療など多岐にわたります。市場開拓の原動力となっているのは、シーケンス技術の技術的進歩、健康におけるマイクロバイオームの役割に対する意識の高まり、研究開発投資の増加です。新たなビジネス機会は、メタゲノム分析が個人のマイクロバイオーム組成に基づいてオーダーメイドの健康ソリューションを提供する個別化医療や、サステイナブル作物管理ソリューションを提供する農業にあります。課題としては、高いコスト、データ分析の複雑さ、データの解釈を妨げる参照データベースの制限などが挙げられます。バイオインフォマティクスツールの革新、シーケンスコストの削減、異業種コラボレーションの強化を通じてこれらの課題に対処することで、市場拡大を促進できる可能性があります。研究革新の主要セグメントには、より高速でコスト効率の高いシーケンス技術の開発や、複雑なメタゲノムデータを正確に解釈するための予測分析などがあります。市場は急速な技術進化を特徴としており、各企業が差別化されたソリューションを提供しようと努力するため、競争の激しい状況となっています。この市場で利益を得ようとする企業への提言としては、先進的なシーケンシングプラットフォームの研究開発への投資、技術交換のための戦略的提携、包括的なマイクロバイオーム・プロファイリングと解釈サービスを含むサービス提供の拡大に注力することなどが挙げられます。全体として、様々なセグメントにおけるメタゲノムシーケンスの統合は、その変革の可能性を浮き彫りにしているが、市場参入企業はサステイナブル成長のために課題を克服し、機会を活用しなければならないです。

市場力学：急速に進化するメタゲノムシーケンス市場の主要市場洞察を公開

メタゲノムシーケンス市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネス機会の獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 細菌の多様性の評価と様々な微生物の検出に対するニーズの高まり
  • 世界の遺伝性疾患の蔓延
  • シーケンシングプロジェクトのための政府と民間セクターによる投資の増加
• 市場抑制要因
  • シーケンシングデータの保存場所が限られている
  • 発展途上国のエンドユーザーにとっては高価格
• 市場機会
  • メタゲノムシーケンスデータ管理のための技術進歩
  • より良いメタゲノムシーケンスのための技術開発
• 市場課題
  • 熟練した経験豊富な人材の不足

ポーターのファイブフォース：メタゲノムシーケンス市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、メタゲノムシーケンス市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：メタゲノムシーケンス市場における外部からの影響の把握

外部マクロ環境要因は、メタゲノムシーケンス市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：メタゲノムシーケンス市場における競合情勢の把握

メタゲノムシーケンス市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：メタゲノムシーケンス市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、メタゲノムシーケンス市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：メタゲノムシーケンス市場における成功への道筋を描く

メタゲノムシーケンス市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力を評価します。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 細菌の多様性の評価とさまざまな微生物の検出の必要性の高まり
    • 世界中で遺伝性疾患の罹患率が増加
    • 政府と民間セクターによるシークエンシングプロジェクトへの投資増加
  • 抑制要因
    • シーケンスデータの保存容量が限られている
    • 新興諸国のエンドユーザーにとって価格が高い
  • 機会
    • メタゲノムシーケンスデータ管理の技術的進歩
    • より良いメタゲノムシーケンスのための技術開発
  • 課題
    • 熟練した経験豊富な労働力の不足
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 メタゲノムシーケンス市場：製品・サービス別

• イントロダクション
• 分析とデータ解釈ソリューション
• 機器
• 試薬・消耗品
• サービス

第7章 メタゲノムシーケンス市場：ワークフロー別

• イントロダクション
• データ処理と分析
• サンプル処理とライブラリの準備
• シーケンシング

第8章 メタゲノムシーケンス市場：技術別

• イントロダクション
• 16S rRNAシークエンシング
• メタトランスクリプトミクス
• ショットガンメタゲノムシーケンス
• 全ゲノムシーケンシングとDe Novoアセンブリ

第9章 メタゲノムシーケンス市場：用途別

• イントロダクション
• 臨床診断
• 創薬
• 生態学と環境用途
• 産業用途
• 土壌微生物叢用途
• 獣医用途

第10章 南北アメリカのメタゲノムシーケンス市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋のメタゲノムシーケンス市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカのメタゲノムシーケンス市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Azenta US, Inc.
• BGI Genomics Co., Ltd.
• CosmosID
• DNASTAR, Inc.
• Eurofins Genomics Germany GmbH
• Freenome Holdings, Inc.
• IntegraGen S.A.
• Macrogen Europe BV
• Microsynth AG
• Novogene Co., Ltd.
• Oxford Nanopore Technologies PLC
• Pacific Biosciences of California, Inc.
• PerkinElmer Inc.
• Psomagen, Inc.
• QIAGEN GmbH

LIST OF FIGURES

• FIGURE 1. METAGENOMIC SEQUENCING MARKET RESEARCH PROCESS
• FIGURE 2. METAGENOMIC SEQUENCING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS METAGENOMIC SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS METAGENOMIC SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC METAGENOMIC SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC METAGENOMIC SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA METAGENOMIC SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA METAGENOMIC SEQUENCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. METAGENOMIC SEQUENCING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. METAGENOMIC SEQUENCING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. METAGENOMIC SEQUENCING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. METAGENOMIC SEQUENCING MARKET DYNAMICS
• TABLE 7. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY ANALYSIS & DATA INTERPRETATION SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY DATA PROCESSING & ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY SAMPLE PROCESSING & LIBRARY PREPARATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY 16S RRNA SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY METATRANSCRIPTOMICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY SHOTGUN METAGENOMIC SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY WHOLE-GENOME SEQUENCING & DE NOVO ASSEMBLY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY ECOLOGICAL & ENVIRONMENTAL APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY INDUSTRIAL APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY SOIL MICROBIOME APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL METAGENOMIC SEQUENCING MARKET SIZE, BY VETERINARY APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS METAGENOMIC SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. CANADA METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 42. CANADA METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 43. CANADA METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 44. CANADA METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. MEXICO METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 46. MEXICO METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 47. MEXICO METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 48. MEXICO METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 50. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 51. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES METAGENOMIC SEQUENCING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 54. ASIA-PACIFIC METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 55. ASIA-PACIFIC METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 56. ASIA-PACIFIC METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 57. ASIA-PACIFIC METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. ASIA-PACIFIC METAGENOMIC SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 59. AUSTRALIA METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 60. AUSTRALIA METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 61. AUSTRALIA METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 62. AUSTRALIA METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. CHINA METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 64. CHINA METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 65. CHINA METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 66. CHINA METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. INDIA METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 68. INDIA METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 69. INDIA METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 70. INDIA METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. INDONESIA METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 72. INDONESIA METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 73. INDONESIA METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 74. INDONESIA METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. JAPAN METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 76. JAPAN METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 77. JAPAN METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 78. JAPAN METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. MALAYSIA METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 80. MALAYSIA METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 81. MALAYSIA METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 82. MALAYSIA METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. PHILIPPINES METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 84. PHILIPPINES METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 85. PHILIPPINES METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 86. PHILIPPINES METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. SINGAPORE METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 88. SINGAPORE METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 89. SINGAPORE METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 90. SINGAPORE METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. SOUTH KOREA METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 92. SOUTH KOREA METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 93. SOUTH KOREA METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 94. SOUTH KOREA METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. TAIWAN METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 96. TAIWAN METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 97. TAIWAN METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 98. TAIWAN METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. THAILAND METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 100. THAILAND METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 101. THAILAND METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 102. THAILAND METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. VIETNAM METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 104. VIETNAM METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 105. VIETNAM METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 106. VIETNAM METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 107. EUROPE, MIDDLE EAST & AFRICA METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 108. EUROPE, MIDDLE EAST & AFRICA METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 109. EUROPE, MIDDLE EAST & AFRICA METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 110. EUROPE, MIDDLE EAST & AFRICA METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 111. EUROPE, MIDDLE EAST & AFRICA METAGENOMIC SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 112. DENMARK METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 113. DENMARK METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 114. DENMARK METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 115. DENMARK METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 116. EGYPT METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 117. EGYPT METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 118. EGYPT METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 119. EGYPT METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 120. FINLAND METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 121. FINLAND METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 122. FINLAND METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 123. FINLAND METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 124. FRANCE METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 125. FRANCE METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 126. FRANCE METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 127. FRANCE METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 128. GERMANY METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 129. GERMANY METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 130. GERMANY METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 131. GERMANY METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 132. ISRAEL METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 133. ISRAEL METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 134. ISRAEL METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 135. ISRAEL METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 136. ITALY METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 137. ITALY METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 138. ITALY METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 139. ITALY METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 140. NETHERLANDS METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 141. NETHERLANDS METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 142. NETHERLANDS METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 143. NETHERLANDS METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. NIGERIA METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 145. NIGERIA METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 146. NIGERIA METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 147. NIGERIA METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 148. NORWAY METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 149. NORWAY METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 150. NORWAY METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 151. NORWAY METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 152. POLAND METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 153. POLAND METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 154. POLAND METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 155. POLAND METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 156. QATAR METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 157. QATAR METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 158. QATAR METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 159. QATAR METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 160. RUSSIA METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 161. RUSSIA METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 162. RUSSIA METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 163. RUSSIA METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 164. SAUDI ARABIA METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 165. SAUDI ARABIA METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 166. SAUDI ARABIA METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 167. SAUDI ARABIA METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 168. SOUTH AFRICA METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 169. SOUTH AFRICA METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 170. SOUTH AFRICA METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 171. SOUTH AFRICA METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 172. SPAIN METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 173. SPAIN METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 174. SPAIN METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 175. SPAIN METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 176. SWEDEN METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 177. SWEDEN METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 178. SWEDEN METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 179. SWEDEN METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 180. SWITZERLAND METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 181. SWITZERLAND METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 182. SWITZERLAND METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 183. SWITZERLAND METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 184. TURKEY METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 185. TURKEY METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 186. TURKEY METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 187. TURKEY METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 188. UNITED ARAB EMIRATES METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 189. UNITED ARAB EMIRATES METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 190. UNITED ARAB EMIRATES METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 191. UNITED ARAB EMIRATES METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 192. UNITED KINGDOM METAGENOMIC SEQUENCING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 193. UNITED KINGDOM METAGENOMIC SEQUENCING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
• TABLE 194. UNITED KINGDOM METAGENOMIC SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 195. UNITED KINGDOM METAGENOMIC SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 196. METAGENOMIC SEQUENCING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 197. METAGENOMIC SEQUENCING MARKET, FPNV POSITIONING MATRIX, 2023

The Metagenomic Sequencing Market was valued at USD 2.15 billion in 2023, expected to reach USD 2.39 billion in 2024, and is projected to grow at a CAGR of 12.43%, to USD 4.89 billion by 2030.

Metagenomic sequencing is a revolutionary approach in genomics that analyzes the genetic material from environmental samples, enabling the comprehensive study of microbial communities without the need for culturing. This approach is crucial for understanding complex microbiomes in environments such as soil, oceans, and human gut flora. Its applications span multiple fields, including clinical diagnostics, where it aids in detecting pathogen outbreaks, agriculture for soil health assessment, and bioremediation efforts to clean pollutants. The end-use scope extends across pharmaceutical industries, environmental agencies, academic research institutions, and healthcare. Market growth is driven by technological advancements in sequencing technologies, growing awareness about microbiomes' roles in health, and increased investment in research and development. Emerging opportunities lie in personalized medicine, where metagenomics can offer tailored health solutions based on individual microbiome compositions, and in agriculture, providing sustainable crop management solutions. Challenges include high costs, data analysis complexity, and limited reference databases, which can impede data interpretation. Addressing these challenges through innovation in bioinformatics tools, reducing sequencing costs, and enhancing cross-industry collaborations could facilitate market expansion. Key areas for research innovation include developing faster, more cost-effective sequencing technologies and predictive analytics to interpret complex metagenomic data accurately. The market is characterized by rapid technological evolution, leading to a highly competitive landscape as companies strive to offer differentiated solutions. Recommendations for businesses looking to capitalize on this market involve investing in R&D for advanced sequencing platforms, forming strategic alliances for technology exchange, and focusing on expanding service offerings to include comprehensive microbiome profiling and interpretation services. Overall, the integration of metagenomic sequencing in various sectors highlights its transformative potential, but market participants must navigate challenges and leverage opportunities for sustainable growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Metagenomic Sequencing Market

The Metagenomic Sequencing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising need for the evaluation of bacterial diversity and detection of various microbes
  • Growing prevalence of genetic disorders worldwide
  • Rising investment by government and private sector for sequencing projects
• Market Restraints
  • Limited storage for the sequencing data
  • High price for the end-user in developing countries
• Market Opportunities
  • Technological advancement for the metagenomic sequencing data management
  • Technological development for better metagenomic sequencing
• Market Challenges
  • Dearth of skilled and experienced workforce

Porter's Five Forces: A Strategic Tool for Navigating the Metagenomic Sequencing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Metagenomic Sequencing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Metagenomic Sequencing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Metagenomic Sequencing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Metagenomic Sequencing Market

A detailed market share analysis in the Metagenomic Sequencing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Metagenomic Sequencing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Metagenomic Sequencing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Metagenomic Sequencing Market

A strategic analysis of the Metagenomic Sequencing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Metagenomic Sequencing Market, highlighting leading vendors and their innovative profiles. These include Azenta US, Inc., BGI Genomics Co., Ltd., CosmosID, DNASTAR, Inc., Eurofins Genomics Germany GmbH, Freenome Holdings, Inc., IntegraGen S.A., Macrogen Europe BV, Microsynth AG, Novogene Co., Ltd., Oxford Nanopore Technologies PLC, Pacific Biosciences of California, Inc., PerkinElmer Inc., Psomagen, Inc., and QIAGEN GmbH.

Market Segmentation & Coverage

This research report categorizes the Metagenomic Sequencing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product & Service, market is studied across Analysis & Data Interpretation Solutions, Instruments, Reagents & Consumables, and Services.
• Based on Workflow, market is studied across Data Processing & Analysis, Sample Processing & Library Preparation, and Sequencing.
• Based on Technology, market is studied across 16S rRNA Sequencing, Metatranscriptomics, Shotgun Metagenomic Sequencing, and Whole-genome Sequencing & De Novo Assembly.
• Based on Application, market is studied across Clinical Diagnostics, Drug Discovery, Ecological & Environmental Applications, Industrial applications, Soil Microbiome Applications, and Veterinary Applications.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising need for the evaluation of bacterial diversity and detection of various microbes
    • 5.1.1.2. Growing prevalence of genetic disorders worldwide
    • 5.1.1.3. Rising investment by government and private sector for sequencing projects
  • 5.1.2. Restraints
    • 5.1.2.1. Limited storage for the sequencing data
    • 5.1.2.2. High price for the end-user in developing countries
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancement for the metagenomic sequencing data management
    • 5.1.3.2. Technological development for better metagenomic sequencing
  • 5.1.4. Challenges
    • 5.1.4.1. Dearth of skilled and experienced workforce
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Metagenomic Sequencing Market, by Product & Service

• 6.1. Introduction
• 6.2. Analysis & Data Interpretation Solutions
• 6.3. Instruments
• 6.4. Reagents & Consumables
• 6.5. Services

7. Metagenomic Sequencing Market, by Workflow

• 7.1. Introduction
• 7.2. Data Processing & Analysis
• 7.3. Sample Processing & Library Preparation
• 7.4. Sequencing

8. Metagenomic Sequencing Market, by Technology

• 8.1. Introduction
• 8.2. 16S rRNA Sequencing
• 8.3. Metatranscriptomics
• 8.4. Shotgun Metagenomic Sequencing
• 8.5. Whole-genome Sequencing & De Novo Assembly

9. Metagenomic Sequencing Market, by Application

• 9.1. Introduction
• 9.2. Clinical Diagnostics
• 9.3. Drug Discovery
• 9.4. Ecological & Environmental Applications
• 9.5. Industrial applications
• 9.6. Soil Microbiome Applications
• 9.7. Veterinary Applications

10. Americas Metagenomic Sequencing Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Metagenomic Sequencing Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Metagenomic Sequencing Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Azenta US, Inc.
• 2. BGI Genomics Co., Ltd.
• 3. CosmosID
• 4. DNASTAR, Inc.
• 5. Eurofins Genomics Germany GmbH
• 6. Freenome Holdings, Inc.
• 7. IntegraGen S.A.
• 8. Macrogen Europe BV
• 9. Microsynth AG
• 10. Novogene Co., Ltd.
• 11. Oxford Nanopore Technologies PLC
• 12. Pacific Biosciences of California, Inc.
• 13. PerkinElmer Inc.
• 14. Psomagen, Inc.
• 15. QIAGEN GmbH